DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Tivozanib is an investigational drug.
There have been 32 clinical trials for Tivozanib. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2010.
The most common disease conditions in clinical trials are Carcinoma, Carcinoma, Renal Cell, and Colorectal Neoplasms. The leading clinical trial sponsors are AVEO Pharmaceuticals, Inc., National Comprehensive Cancer Network, and National Cancer Institute (NCI).
Recent Clinical Trials for Tivozanib
|Phase I/II Study Evaluating Safety and Efficacy of Tivozanib (AV-951) in Cholangiocarcinoma||National Cancer Institute (NCI)||Phase 1/Phase 2|
|A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular Carcinoma||AstraZeneca||Phase 1/Phase 2|
|A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular Carcinoma||AVEO Pharmaceuticals, Inc.||Phase 1/Phase 2|